(Q38635409)

5 September 2017

title

Immunotherapy of Fungal Infections (English)

1 reference

5 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Mawieh Hamad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 November 2015

1 reference

Immunological Investigations

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

738-776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Calcineurin is essential for virulence in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Hydrophobins--unique fungal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Calcineurin is essential for Candida albicans survival in serum and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunomodulatory activities of small host defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Beta-glucan-CRM197 conjugates as candidates antifungal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Fungal rhinosinusitis: what every allergist should know

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Saccharomyces cerevisiae as a vaccine against coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

T cell vaccination in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Adverse effects of anticancer agents that target the VEGF pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

New drugs and novel targets for treatment of invasive fungal infections in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Radioimmunotherapy of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Characterization of gp70 and Anti-gp70 Monoclonal Antibodies inParacoccidioides brasiliensisPathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Anti-CD25 treatment depletes Treg cells and decreases disease severity in susceptible and resistant mice infected with Paracoccidioides brasiliensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Management of Cryptococcus gattii meningoencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The safety and side effects of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Efungumab and caspofungin: pre-clinical data supporting synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

BCG-induced trained immunity in NK cells: Role for non-specific protection to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Antibody Peptide based antifungal immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protective efficacy of antigenic fractions in mouse models of cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Interleukin-17 as an effector molecule of innate and acquired immunity against infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

An immunomodulatory activity of micafungin in preclinical aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Emerging drugs and vaccines for candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Histoplasmosis in Idaho and Montana, USA, 2012-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The Cryptococcus neoformans capsule: a sword and a shield

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The role of neutrophils in the development and outcome of zygomycosis in haematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The damage-response framework of microbial pathogenesis and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

What is infectiveness and how is it involved in infection and immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Identification of Aspergillus fumigatus Surface Components That Mediate Interaction of Conidia and Hyphae With Human Platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Interleukin-12 and host defense against murine Pneumocystis pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Boosting antimicrobial peptides by hydrophobic oligopeptide end tags

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Granulocyte transfusions in children and young adults: does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A fungicidal monoclonal antibody protects against murine invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccines for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Pleurocidin-derived antifungal peptides with selective membrane-disruption effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

More is not necessarily better: prozone-like effects in passive immunization with IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Breaking the mould - novel diagnostic and therapeutic strategies for invasive pulmonary aspergillosis in the immune deficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Mold allergens in respiratory allergy: from structure to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Phenotypic and functional evaluations of peripheral blood monocytes from chronic-form paracoccidioidomycosis patients before and after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

C-type lectin receptors differentially induce th17 cells and vaccine immunity to the endemic mycosis of North America

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

A subset of IL-17(+) mesenchymal stem cells possesses anti-Candida albicans effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

The capsule of the fungal pathogen Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Cloning of porcine NRAMP1 and its induction by lipopolysaccharide, tumor necrosis factor alpha, and interleukin-1beta: role of CD14 and mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2015.1093913

10.3109/08820139.2015.1093913

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26575463%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference